Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (10)
2021
-
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2019
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672
2015
-
Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease
International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373
2012
-
Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma
PLoS ONE, Vol. 7, Núm. 9
-
Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype
Mutagenesis, Vol. 27, Núm. 6, pp. 771-777
2011
-
The changing face of hospitalisation due to gastrointestinal bleeding and perforation
Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 585-591
2007
-
Effects of long-term cyclo-oxygenase 2 selective and acid inhibition on Barrett's oesophagus
Alimentary Pharmacology and Therapeutics, Vol. 26, Núm. 6, pp. 913-923
2006
2005
-
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use
American Journal of Gastroenterology, Vol. 100, Núm. 8, pp. 1685-1693